Supplemental Annuity Collective Trust (SACT) of New Jersey’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$605K	–	218
2022 Q3	$605K	Hold	4,000	–	–	0.26%	111
2022 Q2	$583K	Hold	4,000	–	–	0.23%	125
2022 Q1	$474K	Hold	4,000	–	–	0.16%	163
2021 Q4	$551K	Hold	4,000	–	–	0.17%	159
2021 Q3	$556K	Hold	4,000	–	–	0.18%	156
2021 Q2	$388K	Hold	4,000	–	–	0.13%	187
2021 Q1	$273K	Hold	4,000	–	–	0.09%	203
2020 Q4	$343K	Hold	4,000	–	–	0.13%	180
2020 Q3	$260K	Hold	4,000	–	–	0.11%	189
2020 Q2	$292K	Buy	+4,000	New	+$213K	0.13%	179
2020 Q1	–	Sell	-4,000	Closed	-$218K	–	228
2019 Q4	$218K	Buy	+4,000	New	+$198K	0.09%	217

Other funds holding BHVN

LIP

Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's BHVN Position: Q4 2022 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 4,000 shares — an estimated $605K sold.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in BHVN in Q4 2019 and held it in 11 quarters. The position peaked at $605K in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

Supplemental Annuity Collective Trust (SACT) of New Jersey reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
Supplemental Annuity Collective Trust (SACT) of New Jersey sold 4,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $605K.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019 and held it in 11 quarters.
Supplemental Annuity Collective Trust (SACT) of New Jersey's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $605K in Q3 2022.
7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q4 2022, filed 26 Jan 2023.